Moderna slips
Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...
In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...
Representatives of Moderna Biotech UK and NHS England will also be questioned by the inquiry, led by crossbench peer Baroness ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
Watch live as Kemi Badenoch gives evidence to the UK Covid inquiry on Wednesday, 27 January. The inquiry will also hear from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback